231 related articles for article (PubMed ID: 36398426)
1. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.
Hlophe YN; Joubert AM
J Cell Mol Med; 2022 Dec; 26(23):5743-5754. PubMed ID: 36398426
[TBL] [Abstract][Full Text] [Related]
2. Decoding the synergistic potential of MAZ-51 and zingerone as therapy for melanoma treatment in alignment with sustainable development goals.
Letsoalo K; Nortje E; Patrick S; Nyakudya T; Hlophe Y
Cell Biochem Funct; 2024 Mar; 42(2):e3950. PubMed ID: 38348768
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.
Spinella F; Caprara V; Di Castro V; Rosanò L; Cianfrocca R; Natali PG; Bagnato A
J Mol Med (Berl); 2013 Mar; 91(3):395-405. PubMed ID: 22965194
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells.
Abedi H; Zachary I
J Biol Chem; 1997 Jun; 272(24):15442-51. PubMed ID: 9182576
[TBL] [Abstract][Full Text] [Related]
6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
8. The role of the VEGF-C/VEGFR-3 axis in cancer progression.
Su JL; Yen CJ; Chen PS; Chuang SE; Hong CC; Kuo IH; Chen HY; Hung MC; Kuo ML
Br J Cancer; 2007 Feb; 96(4):541-5. PubMed ID: 17164762
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes.
Igarashi Y; Chosa N; Sawada S; Kondo H; Yaegashi T; Ishisaki A
Int J Mol Med; 2016 Apr; 37(4):1005-13. PubMed ID: 26934950
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
Coso S; Zeng Y; Opeskin K; Williams ED
PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
[TBL] [Abstract][Full Text] [Related]
11. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
12. ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome.
Zhang L; Ye C; Li P; Li C; Shu W; Zhao Y; Wang X
Stem Cell Res Ther; 2022 Sep; 13(1):448. PubMed ID: 36064450
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
Chen H; Suo K; Cheng Y; Zheng B; Xu L
Gynecol Endocrinol; 2013 Jan; 29(1):20-4. PubMed ID: 22817694
[TBL] [Abstract][Full Text] [Related]
14. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
Iwami D; Brinkman CC; Bromberg JS
Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
[TBL] [Abstract][Full Text] [Related]
16. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.
Ganju RK; Brubaker SA; Meyer J; Dutt P; Yang Y; Qin S; Newman W; Groopman JE
J Biol Chem; 1998 Sep; 273(36):23169-75. PubMed ID: 9722546
[TBL] [Abstract][Full Text] [Related]
17. Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor.
Liao WX; Feng L; Zheng J; Chen DB
Endocrinology; 2010 Jul; 151(7):3432-44. PubMed ID: 20463056
[TBL] [Abstract][Full Text] [Related]
18. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
20. Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.
Han KY; Chang JH; Dugas-Ford J; Alexander JS; Azar DT
FEBS Lett; 2014 Nov; 588(23):4357-63. PubMed ID: 25281926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
